[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":538,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.15,"TPM_sd":12.95,"TPM_min":0.08,"TPM_25th_percentile":1.9,"TPM_median":3.67,"TPM_75th_percentile":7.94,"TPM_max":117.72},{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":75,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.14,"TPM_sd":11.44,"TPM_min":0.04,"TPM_25th_percentile":1.06,"TPM_median":2.37,"TPM_75th_percentile":4.9,"TPM_max":91.79},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":168,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.51,"TPM_sd":0.82,"TPM_min":0,"TPM_25th_percentile":0.1,"TPM_median":0.23,"TPM_75th_percentile":0.49,"TPM_max":5.21},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.43,"TPM_sd":0.35,"TPM_min":0,"TPM_25th_percentile":0.19,"TPM_median":0.36,"TPM_75th_percentile":0.52,"TPM_max":1.41},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":19,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.3,"TPM_sd":0.65,"TPM_min":0.14,"TPM_25th_percentile":0.77,"TPM_median":1.3,"TPM_75th_percentile":1.84,"TPM_max":2.27},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.4,"TPM_sd":0.67,"TPM_min":0.46,"TPM_25th_percentile":1.26,"TPM_median":1.53,"TPM_75th_percentile":1.67,"TPM_max":2.06},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":24,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.96,"TPM_sd":4.18,"TPM_min":0.15,"TPM_25th_percentile":0.91,"TPM_median":1.8,"TPM_75th_percentile":6.41,"TPM_max":14.53},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.66,"TPM_sd":4.65,"TPM_min":0.7,"TPM_25th_percentile":1.08,"TPM_median":1.66,"TPM_75th_percentile":3.62,"TPM_max":12.82},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":28.94,"TPM_sd":22.79,"TPM_min":2.25,"TPM_25th_percentile":14.75,"TPM_median":21.78,"TPM_75th_percentile":50.91,"TPM_max":64.13},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.93,"TPM_sd":3.08,"TPM_min":0.41,"TPM_25th_percentile":1.33,"TPM_median":1.96,"TPM_75th_percentile":3.56,"TPM_max":7.4},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.48,"TPM_sd":0.32,"TPM_min":0.16,"TPM_25th_percentile":0.26,"TPM_median":0.41,"TPM_75th_percentile":0.57,"TPM_max":1.21},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4,"TPM_sd":6.52,"TPM_min":0.17,"TPM_25th_percentile":0.23,"TPM_median":0.3,"TPM_75th_percentile":5.91,"TPM_max":11.52},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":63,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.21,"TPM_sd":9.44,"TPM_min":0.36,"TPM_25th_percentile":2.37,"TPM_median":4.97,"TPM_75th_percentile":10.11,"TPM_max":59.85},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.39,"TPM_sd":1.41,"TPM_min":0.93,"TPM_25th_percentile":2.82,"TPM_median":3.04,"TPM_75th_percentile":4.14,"TPM_max":5.85},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":18,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.13,"TPM_sd":3.18,"TPM_min":0.47,"TPM_25th_percentile":1.06,"TPM_median":4.14,"TPM_75th_percentile":7.08,"TPM_max":9.24},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.68,"TPM_sd":2.94,"TPM_min":4.18,"TPM_25th_percentile":5.25,"TPM_median":5.96,"TPM_75th_percentile":6.25,"TPM_max":11.74},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":54.85,"TPM_sd":13.69,"TPM_min":39.83,"TPM_25th_percentile":48.96,"TPM_median":58.09,"TPM_75th_percentile":62.37,"TPM_max":66.64},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":27.9,"TPM_sd":38.81,"TPM_min":0.29,"TPM_25th_percentile":5.72,"TPM_median":11.14,"TPM_75th_percentile":41.7,"TPM_max":72.27},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":69,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.11,"TPM_sd":1.36,"TPM_min":0.02,"TPM_25th_percentile":0.43,"TPM_median":0.7,"TPM_75th_percentile":1.09,"TPM_max":7.9},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":19,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.02,"TPM_sd":1.4,"TPM_min":0.32,"TPM_25th_percentile":0.77,"TPM_median":1.76,"TPM_75th_percentile":3.28,"TPM_max":4.61},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":36,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.04,"TPM_sd":1.68,"TPM_min":0.46,"TPM_25th_percentile":0.94,"TPM_median":1.27,"TPM_75th_percentile":2.76,"TPM_max":6.68},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.86,"TPM_sd":2.51,"TPM_min":0.91,"TPM_25th_percentile":1.29,"TPM_median":1.66,"TPM_75th_percentile":3.5,"TPM_max":7.55},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 122)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":89,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.54,"TPM_sd":11.92,"TPM_min":0.15,"TPM_25th_percentile":2.38,"TPM_median":5.13,"TPM_75th_percentile":10.51,"TPM_max":59.91},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 122)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":33,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.07,"TPM_sd":27.33,"TPM_min":0.41,"TPM_25th_percentile":0.73,"TPM_median":2.97,"TPM_75th_percentile":6.74,"TPM_max":135.87},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 83)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.92,"TPM_sd":2.25,"TPM_min":0.28,"TPM_25th_percentile":1.33,"TPM_median":2.59,"TPM_75th_percentile":3.87,"TPM_max":12.52},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 83)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":19,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.59,"TPM_sd":2.62,"TPM_min":0.48,"TPM_25th_percentile":1.94,"TPM_median":2.81,"TPM_75th_percentile":4.16,"TPM_max":11.08},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":105,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":27.84,"TPM_sd":18.69,"TPM_min":3.21,"TPM_25th_percentile":15.46,"TPM_median":24.29,"TPM_75th_percentile":32.75,"TPM_max":101.39},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":22.18,"TPM_sd":13.47,"TPM_min":1.74,"TPM_25th_percentile":15.61,"TPM_median":20.66,"TPM_75th_percentile":29.32,"TPM_max":51.3},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"Orphanet_2495","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.68,"TPM_sd":0.5,"TPM_min":0.16,"TPM_25th_percentile":0.39,"TPM_median":0.58,"TPM_75th_percentile":0.78,"TPM_max":2.03},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"Orphanet_2495","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.74,"TPM_sd":0.57,"TPM_min":0.03,"TPM_25th_percentile":0.42,"TPM_median":0.57,"TPM_75th_percentile":0.99,"TPM_max":1.77},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 315)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":303,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":50.8,"TPM_sd":42.85,"TPM_min":0.65,"TPM_25th_percentile":23.78,"TPM_median":37.92,"TPM_75th_percentile":63.68,"TPM_max":332.67},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 315)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":46.08,"TPM_sd":43.21,"TPM_min":0.27,"TPM_25th_percentile":16.03,"TPM_median":37.52,"TPM_75th_percentile":58.66,"TPM_max":132.41},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":80.71,"TPM_sd":50.21,"TPM_min":1.85,"TPM_25th_percentile":45.47,"TPM_median":70.78,"TPM_75th_percentile":111.43,"TPM_max":332.67},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":64.12,"TPM_sd":42.02,"TPM_min":13.96,"TPM_25th_percentile":39.32,"TPM_median":47.7,"TPM_75th_percentile":87.73,"TPM_max":132.41},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.45,"TPM_sd":0.26,"TPM_min":0.08,"TPM_25th_percentile":0.26,"TPM_median":0.41,"TPM_75th_percentile":0.6,"TPM_max":0.94},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.56,"TPM_sd":0.59,"TPM_min":0.08,"TPM_25th_percentile":0.16,"TPM_median":0.34,"TPM_75th_percentile":0.7,"TPM_max":1.65},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 128)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":108,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.28,"TPM_sd":1.78,"TPM_min":0.34,"TPM_25th_percentile":1.9,"TPM_median":3.1,"TPM_75th_percentile":4.24,"TPM_max":9.55},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 128)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.17,"TPM_sd":1.45,"TPM_min":0.04,"TPM_25th_percentile":1.01,"TPM_median":1.9,"TPM_75th_percentile":2.66,"TPM_max":5.68},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":124,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.44,"TPM_sd":3.57,"TPM_min":0.2,"TPM_25th_percentile":3.48,"TPM_median":6.14,"TPM_75th_percentile":8.78,"TPM_max":17.93},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.36,"TPM_sd":3.06,"TPM_min":2.28,"TPM_25th_percentile":4.93,"TPM_median":5.83,"TPM_75th_percentile":9.29,"TPM_max":9.49}]